News
2d
AllAfrica on MSNAfrica: Scientists, Activists Rally at #IAS2025 to Protect HIV ProgressAs science soars with game-changing HIV tools, a funding crisis threatens to ground progress "We come together at a pivotal ...
The recognition came just weeks after the Seventy-eighth World Health Assembly approved the Agreement in May 2025, marking ...
The number of mpox cases in Guinea since an outbreak was first detected has passed 200, health officials told AFP Friday, ...
1d
News Medical on MSNWHO: Over 14 million infants not vaccinatedIn 2024, 89% of infants globally—about 115 million—received at least one dose of the diphtheria, tetanus, and pertussis (DTP) ...
WHO endorses biannual injectable Lenacapavir for HIV prevention. This long-acting PrEP offers hope for high-risk groups and ...
Saima Wazed Putul, the World Health Organization’s (WHO) controversial regional director for the South East Asia Regional ...
19h
AllAfrica on MSNRwanda: 10 Things to Know About Effectiveness of New HIV Injectable DrugGlobally, an estimated 4,000 adolescent girls and young women become infected with HIV each week, with sub-Saharan Africa accounting for more than 60% of these new infections, according to the World ...
An estimated 14.3 million children globally remain unvaccinated and vulnerable to vaccine-preventable illnesses – meaning ...
A recent report reveals that an alarming 14.3 million children worldwide remain unvaccinated, with conflict zones posing ...
3d
AllAfrica on MSNMomentum Builds For Long-Acting HIV Solutions As IAS 2025 Spotlights Scientific Progress, Funding Challenges And Leaders' Calls To ActionNew WHO guidelines endorse long-acting injectable lenacapavir for HIV prevention, Medicines Patent Pool expands licence for long-acting injectable cabotegravir for treatment, and Merck’s once-monthly ...
A WHO and UNICEF report has found that global childhood vaccine rates held steady in 2024, but that worrying gaps remain.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results